| Nutritional status affects fluvastatin-induced hepatotoxicity and myopathy in rats. | |
| | |
MedLine Citation:
|
PMID: 20587623 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Rats that consumed a high-fat and high-sucrose diet (HF diet) developed hepatic steatosis. Treatment of HF diet-fed rats with fluvastatin (8 mg/kg) was lethal, followed by an elevation in levels of plasma aspartate aminotransferase and creatine kinase activities and skeletal muscle toxicity. This study was conducted to determine whether nutritional status affects statin-induced adverse effects in rats. Fluvastatin treatment of rats fed the HF diet led to an increase in systemic exposure, suggesting altered metabolism and elimination. In fact, although hepatic multidrug resistance-associated protein (Mrp) 2 and multidrug resistance (Mdr) 1b protein levels were not significantly changed by fluvastatin treatment for 8 days of rats fed a HF diet, the organic anion-transporting protein (Oatp) 1, Mrp3, CYP1A, CYP2C, UDP-glucuronosyltransferase (UGT) 1A1, and UGT1A5 protein levels were moderately decreased and the Oatp2, CYP3A, and UGT2B1 protein levels were markedly suppressed. No significant difference in the baseline level of Oatp1, Oatp2, Mrp2, Mrp3, Mdr1b, CYP1A, CYP2C, CYP3A, UGT1A1, UGT1A5, or UGT2B1 protein was found between the standard diet- and HF diet-fed groups. In addition, the mRNA levels of Oatp2, CYP2C11, and CYP3A1/2 were markedly decreased in HF diet-fed and fluvastatin-treated rats. There was no significant difference in the glucuronidation activities against fluvastatin among the four groups. In liver cell nuclei, levels of constitutive androstane receptor, pregnane X receptor, and hepatocyte nuclear factor 4α proteins were decreased in fluvastatin-treated HF diet-fed rats, which correlated with the decrease in Oatp2, CYP2C, and CYP3A. Taken together, these results indicate that nutritional status may influence adverse effects of fluvastatin by increasing systemic exposure through modulation of hepatic uptake and elimination. |
| | |
Authors:
|
Junko Sugatani; Satoshi Sadamitsu; Masatoshi Kurosawa; Shin-ichi Ikushiro; Toshiyuki Sakaki; Akira Ikari; Masao Miwa |
Related Documents
:
|
17646283 - Prediction of metabolic clearance of bisphenol a (4,4 '-dihydroxy-2,2-diphenylpropane) ... 14637223 - Independent effects of diet palatability and fat content on bout size and daily intake ... 2759973 - Mechanism of enhanced cold tolerance by an ephedrine-caffeine mixture in humans. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-06-29 |
Journal Detail:
|
Title: Drug metabolism and disposition: the biological fate of chemicals Volume: 38 ISSN: 1521-009X ISO Abbreviation: Drug Metab. Dispos. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9421550 Medline TA: Drug Metab Dispos Country: United States |
Other Details:
|
Languages: eng Pagination: 1655-64 Citation Subset: IM |
Affiliation:
|
School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Shizuoka, Japan. sugatani@u-shizuoka-ken.ac.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Influence of cytidine deaminase on antitumor activity of 2'-deoxycytidine analogs in vitro and in vi...
Next Document: Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo.